Skip to main content
Clinical Trials/ACTRN12619000010190
ACTRN12619000010190
Completed
N/A

Investigating the effect of a novel brain stimulation treatment on episodic memory and gamma activity in Mild Alzheimer's Disease

Monash University0 sites30 target enrollmentJanuary 8, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mild Alzheimer's Disease
Sponsor
Monash University
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 8, 2019
End Date
May 24, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged between 50\-85 years
  • \-Demonstrated ability to give informed consent
  • \-Diagnosis of probable AD according to the National Institute of Neurological and Communication Disorders–Alzheimer’s Disease and Related Disorders Association (NINCDS–ADRDA) criteria
  • \-Meet criteria for mild AD as indicated by a score of greater than 19 on the Mini\-Mental State Evaluation (MMSE)
  • \-Not on a cholinesterase inhibitor or memantine or have been on a stable dose for at least two months prior to screening
  • \-Not on psychotropic medication or their dose of psychotropic medication has been unchanged for a minimum of 4 weeks prior to entry into the study
  • \-Frequent contact with a caregiver who can provide information on the participant’s cognitive and functional abilities at study visits and assist with at home stimulation procedures where required
  • \-Able to participate in cognitive testing in English

Exclusion Criteria

  • \-Concomitant major and unstable medical, psychiatric or neurological illness
  • \-Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials